1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Asahi Kasei Corporation

Asahi Kasei Corporation

AHKSY
Asahi Kasei CorporationUS flagOther OTC
22.54
USD
-0.56
- -
15.29BMarket Cap
Asahi Kasei Corporation
AHKSY
(Other OTC)

Recent

price

22.54

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
2,225.46
2,250.89
2,384.92
2,715.94
2,843.64
2,779.06
2,696.31
2,925.14
3,109.17
3,099.1
3,035.69
3,548.02
3,931.8
4,017.81
4,472.99
4,529.57
2,075.73
Revenue per Share
86.23
79.79
76.86
144.97
151.25
131.37
164.67
243.85
211.32
149.7
114.98
233.35
-132.59
63.2
198.81
233.95
18.7
Basic EPS, GAAP
113.2
92.43
31.52
211.3
62.91
172.83
110.51
220.03
124.93
-43.2
149.02
19.55
-117.32
177.95
123.04
135.62
119.58
Free Cash Flow per Basic Share
20
26
28
28
38
40
40
56.01
74.02
70.18
66.02
68.02
70.05
72.08
73.58
80.13
36.04
Dividend per Share
832.53
886.76
940.07
1,057.3
1,149.03
1,240.63
1,365.95
1,554.55
1,691.78
1,770.36
1,819.33
1,997.52
1,795.5
1,787.42
1,906.33
2,059.78
1,837.65
Book Value per Share
921.83
964.46
814.27
955.06
1,161.91
805.86
1,010
1,275.63
1,250.22
962.45
1,153.36
1,271.37
1,383.28
1,578.19
1,448.22
1,838.32
1,315.55
Tangible Book Value per Share
699
699
699
699
699
698
698
698
698
694
694
694
693
693
679
679
693
Basic Weighted Avg Shares
1,555,945
1,573,230
1,666,640
1,897,766
1,986,405
1,940,914
1,882,991
2,042,216
2,170,403
2,151,646
2,106,051
2,461,317
2,726,485
2,784,878
3,037,312
3,074,505
1,438,954
Sales/Revenue/Turnover
7.9
6.63
5.52
7.55
7.95
8.51
8.46
9.72
9.66
8.24
8.16
8.23
4.68
5.05
6.98
7.52
5.9
Operating Margin (%)
84,899
79,619
87,039
94,875
95,378
109,632
109,193
113,463
104,046
118,304
133,272
148,129
177,286
182,196
186,106
196,344
93,433
Depreciation Expense
60,288
55,766
53,712
101,297
105,652
91,753
115,001
170,248
147,512
103,931
79,768
161,880
-91,947
43,806
134,997
158,794
12,965
Net Income, GAAP
37.29
40.04
34.51
37.69
32.53
36.19
25.87
21.13
28.79
32.2
45.6
23.84
- -
- -
27.85
23.8
31.19
Effective Tax Rate (%)
3.87
3.54
3.22
5.34
5.32
4.73
6.11
8.34
6.8
4.83
3.79
6.58
-3.37
1.57
4.44
5.16
0.9
Profit Margin (%)
271,883
272,170
216,605
313,619
384,130
130,356
299,665
349,801
369,540
264,899
433,613
410,359
576,032
735,465
804,840
1,072,214
622,004
Working Capital
120,524
92,417
190,980
188,482
171,619
135,169
213,051
163,528
230,131
292,678
434,325
422,500
607,950
656,655
876,747
871,962
738,509
LT Debt
675,602
719,285
824,451
925,767
1,097,722
1,057,400
1,168,115
1,305,213
1,402,710
1,383,461
1,494,534
1,718,816
1,695,383
1,848,625
1,913,944
2,165,648
1,803,449
Total Equity
8.22
6.7
5.65
7.15
8.03
7.23
7.55
9.71
8.55
6.07
4.36
6.52
- -
- -
5.14
5.57
- -
Return on Invested Capital (%)
7.35
6.76
5.97
9.74
9.94
7.64
8.62
12.38
9.78
5.84
4.05
7.85
- -
- -
5.7
6.5
-3.71
Return on Capital (%)
10.79
9.28
8.41
14.52
13.71
10.99
12.63
16.7
13.02
8.62
6.4
12.23
-6.99
3.53
10.66
11.79
1.03
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
298,906
- -
410,095
LT Borrowings
625,926
- -
710,871
LT Finance Leases
30,729
- -
27,638
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,386
- -
1,386
Market Capitalization
1,539,723
1,429,534
1,497,662

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
1,650,037
- -
1,631,710
Cash, Cash Equivalents & STI
338,108
- -
340,999
Accounts Receivable, Net
485,941
- -
463,581
Inventories
678,836
- -
698,637
Total Current Liabilities
914,572
- -
1,009,706
Payables & Accruals
- -
- -
- -
ST Debt
298,906
- -
410,095
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.57%
7.87%
13.15%
Free Cash Flow
-161.98%
-212.08%
10.18%
Net Income, GAAP
3.15%
4.86%
17.63%
Sales/Revenue/Turnover
4.88%
8.01%
1.22%
Total Cash Common Dividend
- -
- -
8.85%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
650,739
695,185
718,222
720,732
2,784,878
2025
- -
- -
- -
- -
3,037,312
2026
- -
- -
- -
- -
3,074,505

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13.84
- -
- -
- -
63.2
2025
- -
- -
- -
- -
198.81
2026
- -
- -
- -
- -
233.95

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
36.05
- -
- -
- -
72.08
2025
- -
- -
- -
- -
73.58
2026
- -
- -
- -
- -
80.13
Similar Companies
Hangjin Technology Co., Ltd. (000818.SZ)
Dymatic Chemicals,Inc. (002054.SZ)
OCI Company Ltd. (010060.KS)
Kazan Public Joint Stock Company Organichesky sintez (KZOS.ME)
Miwon Specialty Chemical Co., Ltd. (268280.KS)
PCC Rokita S.A. (PCR.WA)
Business
Asahi Kasei Corp. (AHKSY) manufactures and markets a diverse range of chemical, electronics, homes, and healthcare products worldwide. The company operates through three primary business sectors: Materials, which encompasses basic chemicals, fibers, performance products, specialty solutions, and electronics including lithium-ion battery separators and semiconductors; Homes, centered on Hebel Haus unit homes, Hebel autoclaved aerated concrete panels, and related construction materials; and Healthcare, which includes pharmaceuticals, medical devices, acute critical care products, and bioprocess solutions such as virus removal filters. Asahi Kasei serves industrial, consumer, and medical markets across Japan, North America, Europe, Asia, and other regions with manufacturing facilities and sales networks in key locations including the United States, Germany, China, and Thailand. Founded in 1931 and headquartered at Hibiya Mitsui Tower in Tokyo, the company recently announced an absorption-type merger between its wholly owned subsidiary Asahi Kasei Advance Corp. and Teijin Frontier Co., Ltd., effective October 1, 2026, forming a joint venture owned 20% by Asahi Kasei to integrate business platforms in sustainable materials; completed the acquisition of Calliditas Therapeutics AB in 2024, enhancing its pharmaceuticals portfolio in rare kidney diseases; and formed a joint venture with Honda for lithium-ion battery separator production in Canada.

Company News

APIChatGPT

  • businesswire.com

    Asahi Kasei's Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing Time

  • businesswire.com

    Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor Packaging

  • businesswire.com

    Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030

  • zacks.com

    Best Value Stocks to Buy for April 30th

  • zacks.com

    New Strong Buy Stocks for April 30th

  • zacks.com

    5 Undervalued Price-to-Sales Stocks That Could Deliver Outsized Gains

  • defenseworld.net

    Critical Comparison: Asahi Kasei (OTCMKTS:AHKSY) vs. TOR Minerals International (OTCMKTS:TORM)

  • zacks.com

    Are Investors Undervaluing Asahi Kasei (AHKSY) Right Now?

  • businesswire.com

    Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy

  • zacks.com

    Asahi Kasei (AHKSY) Upgraded to Strong Buy: What Does It Mean for the Stock?

  • zacks.com

    Best Momentum Stocks to Buy for April 16th

  • zacks.com

    Best Value Stocks to Buy for April 16th

  • zacks.com

    New Strong Buy Stocks for April 16th

  • zacks.com

    5 Bargain Stocks With Low Price-to-Sales Set to Deliver Strong Upside

  • zacks.com

    Should Value Investors Buy Asahi Kasei (AHKSY) Stock?

  • zacks.com

    5 Low Price-to-Sales Stocks to Strengthen Your Investment Portfolio

  • zacks.com

    Is Asahi Kasei (AHKSY) Outperforming Other Basic Materials Stocks This Year?

  • businesswire.com

    Chevron Technology Ventures, Asahi Kasei Invest in Heavy-Industry Robotics Company KEWAZO

  • zacks.com

    Here's Why Asahi Kasei (AHKSY) Could be Great Choice for a Bottom Fisher

  • zacks.com

    Are Investors Undervaluing Asahi Kasei (AHKSY) Right Now?